Welcome to the Program for Attention, Learning, and Memory (PALM)

The Program for Attention, Learning, and Memory (PALM) is dedicated to positively impacting the lives of children and families struggling with ADHD. This is accomplished by two overarching research arms.

  • The first arm of our program is focused on advancing our understanding of neurocognitive deficits (e.g., attention, memory) in children with ADHD. Specifically, we examine how deficits in areas of neurocognition interact to adversely impact core areas of functioning (e.g., attention problems, learning). Developments in this area will lead to an improved understanding of potential causes of many of the difficulties experienced by children with ADHD as well as novel treatment targets.
  • The second arm of our program is focused on examining how a better understanding of neurocognition in individuals with ADHD might be used to improve already existing treatments as well as develop novel treatments targeted at improving underlying neurocognitive dysfunction. Our ultimate hope is that developments in these areas will lead to sustained improvements in functioning for individuals and families dealing with ADHD, particularly as they relate to learning outcomes.

Congratulations to Mileini!

We would like to congratulate the PALM’s graduate student, Mileini Campez, on the recent acceptance of her poster titled: “The Impact of Methylphenidate on Perceptual and Cognitive Mechanisms Underlying Choice Impulsivity in Attention-Deficit/Hyperactivity Disorder (ADHD)”, to the 2017 Association for Behavioral and Cognitive Therapies (ABCT) conference. We are very proud of Milieni and are thrilled she will be representing PALM at ABCT this... read more

The PALM Director Publishes New Collaborative Research Findings

Dr. Joseph Raiker, the Director of the Program for Attention, Learning, and Memory (PALM) recently led a study, in collaboration with his colleagues, assessing the utility of a widely-used clinical rating scale in a community mental health clinic for diagnosing ADHD. This study is the first to provide clinicians with multilevel diagnostic likelihood ratios using these scales in hopes of facilitating their widespread clinical use in the empirically-based assessment of ADHD. You can learn more at the following link in the Journal of the American Academy of Child & Adolescent... read more